SCHEMBL4631032

SCHEMBL4631032

CCCCOC(=O)NC(CCC(=O)O)N(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.42
PLA2G2C Q5R387 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
MCL1 Q07820 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CHRNB2 P17787 3/20 0.40
CHRNA4 P43681 3/20 0.40
EPHX2 P34913 2/20 0.39
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
CTSK P43235 2/20 0.39
ACHE P22303 6/20 0.38
PLA2G10 O15496 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602214 0.87 EPHX1 (0.41) EPHX1ALDH1A1KDM4ENPC1MAPT
SCHEMBL2222653 0.85 EPHX1 (0.45) EPHX1ALDH1A1KDM4ENPC1MAPT
SCHEMBL4603603 0.82 CHRNB2 (0.38) EPHX1ALDH1A1KDM4ENPC1MAPT
SCHEMBL288502 0.80 HRH3 (0.48) EPHX1PLA2G2CNPC1HPGDRAB9A
SCHEMBL26626453 0.80 HRH3 (0.48) EPHX1PLA2G2CNPC1HPGDRAB9A
SCHEMBL283254 0.80 HRH3 (0.48) EPHX1PLA2G2CNPC1HPGDRAB9A
SCHEMBL7447157 0.79 FOLH1 (0.51)
SCHEMBL6168369 0.77 KMT2A (0.49) PLA2G2CMAPK1SMN1; SMN2EPHX2
SCHEMBL7006306 0.77 KMT2A (0.49) PLA2G2CMAPK1SMN1; SMN2EPHX2
SCHEMBL4685971 0.77 SIRT2 (0.43) EPHX1PLA2G2CNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924568-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2008-05-28 EP disclosed
WO-2007011623-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2007-01-25 WO disclosed